This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 21
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purposes of this study are to determine: - If there are any differences in the way LY3202626 is handled by the body when taken in two different forms - Whether a high fat meal affects the way the body handles LY3202626 - How well tolerated LY3202626 is There are three (3) study periods for all participants. Participants will be admitted to the clinical research unit (CRU) each period and will be discharged from the CRU following the completion of 2 overnight stays and up to 36 hours after dosing with LY3202626. The study will last about 50 days, not including screening.

Provided treatments

  • Drug: LY3202626 (R-Fasting)
  • Drug: LY3202626 (T1-Fasting)
  • Drug: LY3202626 (T1-Fed)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03023826. The sponsor of the trial is Eli Lilly and Company and it is looking for 30 volunteers for the current phase.
Official trial title:
Relative Bioavailability and Food Effect Study in Healthy Subjects Administered Two Different Formulations of LY3202626